Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes

BACKGROUND: Alpha-glucosidase inhibitors (AGIs) have been shown to reduce incident type 2 diabetes but their impact on cardiovascular (CV) disease remains controversial. We sought to identify the overall impact of AGIs with respect to incident type 2 diabetes in individuals with impaired glucose tol...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cardiovasc Diabetol
Hlavní autoři: Coleman, Ruth L., Scott, Charles A. B., Lang, Zhihui, Bethel, M. Angelyn, Tuomilehto, Jaakko, Holman, Rury R.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6798440/
https://ncbi.nlm.nih.gov/pubmed/31623625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0933-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky